The event will coincide with the Sino 17th Bioindustries Convention, a key forum for the biopharmaceutical sector, according to a social media post by the business group BioCubafarma.

The meeting, which will bring together more than 80 companies and institutions from China, is convened every two years and aims to evaluate the progress of the strategic alliance in this field agreed upon by both countries to address health problems facing the Chinese, Cuban, and global populations.

In this context, China and Cuba are celebrating more than two decades of cooperation in the biopharmaceutical field.

According to BioCubafarma, the joint venture’s subsidiary, BPL, Abiotech Pharmaceutical, will soon open in the city of Changzhi, for the production of generic and biologic medicines, and innovative pharmaceuticals.

The business group emphasizes that its participation in the event will include conferences and a prominent presence at the exhibition, strengthening mutual strategic ties.

jdt/arm/mem/dl